InsiderTrades

Form 4 for DAR DARLING INGREDIENTS INC.

Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-14 · accession 0000950170-23-043038 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-08-16 2023-08-14 DAR Bullock John EVP Chief Strategy Off S - Sale+OE $65.12 -58.6K 52.5K -53% -$3.82M
D 2023-08-16 2023-08-16 DAR Bullock John EVP Chief Strategy Off G - Gift $0.00 -5,000 52.5K -9% $0
D 2023-08-16 2023-08-14 DAR Bullock John EVP Chief Strategy Off F - Tax $65.48 -19.5K 67.3K -22% -$1.28M
D 2023-08-16 2023-08-14 DAR Bullock John EVP Chief Strategy Off M - OptEx $18.82 +34.4K 86.9K +66% +$647.9K
D 2023-08-16 2023-08-14 DAR Bullock John EVP Chief Strategy Off M - OptEx $0.00 -34.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-14 S D 43,720 $65.00 57,469 D — —
2 Common Common Stock 2023-08-16 G D 5,000 $0.00 52,469 D — — (F1) On 08/16/2023, the reporting person donated 5,000 shares of directly owned shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
3 Common Common Stock 2023-08-14 S D 14,880 $65.48 52,469 D — — (F2) This transaction was executed in multiple trades at prices ranging from $65.44 to $65.57; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
4 Common Common Stock 2023-08-14 F D 19,547 $65.48 67,349 D — —
5 Common Common Stock 2023-08-14 M A 34,427 $18.82 86,896 D — —
6 Derivative Options (right to buy) 2023-08-14 M D 34,427 $0.00 0 D $18.82 · 2021-01-29 to 2028-01-29 34,427 Common Stock (F3) Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 11,476 shares became exercisable on 01/29/2019 and 01/29/2020 and 11,475 shares became exercisable on 01/29/2021.